Drugs Made In America Acquisition Growth Metrics (2025) | DMIIR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Growth Metrics	Dec2025
Growth Ratios
Enterprise Value Growth (1y) (Quarter)	98.69%
Enterprise Value (QoQ) (Quarter)	99.93%

Drugs Made In America Acquisition (DMIIR)

NASDAQ: DMIIR

$0.08 ▼ -0.01 (-5.88%)

Jul 27, 2026 · 2:04 PM UTC